Back to search
FDAFDA · Food and drugs·Recall number Z-0931-2018

Proteus 235, Pencil Beam Scanning version PTS-6.4.11.X The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

Published March 14, 2018 · Recall initiated: October 19, 2017

Summary

FDA records medical device Class II recall Z-0931-2018, published March 14, 2018 and initiated October 19, 2017. Recalling firm: Ion Beam Applications S.A.; Status: Terminated; Reported quantity: 3; Lot: PAT.003 (KR), PAT.006 (US). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Range for the same energy could be different depending if the layer is the first layer of the irradiation plan or not.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ion Beam Applications S.A.
Distributor
US Distribution to the state of :FL
Lot
PAT.003 (KR), PAT.006 (US)
Risk classification
Class II
Area (FDA)
device
Country
Belgium

Related recalls

Questions about this recall

Was Proteus 235, Pencil Beam Scanning version PTS-6.4.11.X The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck. recalled?

Yes. FDA published recall Z-0931-2018 on March 14, 2018. Reported hazard: Range for the same energy could be different depending if the layer is the first layer of the irradiation plan or not.

What should I do if I have this product?

Voluntary: Firm initiated · Letter